Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.32%
Monatliche Änderung
-5.40%
6 month change
-25.87%
Jahresänderung
+104.11%
Vorheriger Schlusskurs
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volumen
21
Märkte
Aktien
Gesundheitswesen
GALT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
8.58 M
12.8 M
7.7 M
6.6 M
3.5 M
30.6 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
10 M
851 K
0
12.94 M
1.3 M
15.09 M
Free cash flow
8.58 M
12.8 M
7.7 M
6.6 M
3.5 M
30.6 M
Nachrichten
Директор Galectin Therapeutics Марк Рубин покинул совет директоров
Galectin Therapeutics director Marc Rubin resigns from board
Финансовый директор Galectin Therapeutics продал акции на $233 тыс.
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Акции Galectin Therapeutics рухнули после отзыва FDA о препарате
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA предоставила отзыв о программе разработки белапектина Galectin
FDA provides feedback on Galectin’s belapectin development program
Директор Galectin Therapeutics продал акции на сумму $1,05 млн
Акционеры Galectin Therapeutics избрали совет директоров